Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Thrombolysis for acute ischemic stroke safe in GI malignancy

Inohara T et al. Circulation. 2018 Nov 6;138[suppl 1], Abstract A12291

Key clinical point: Thrombolysis for acute ischemic stroke appeared safe in patients with a recent GI bleed or malignancy.

Major finding: In-hospital mortality after thrombolysis was 10% in those with a GI bleed or malignancy and 9% in those without.

Study details: A review of Medicare records for 40,396 acute ischemic stroke patients treated with thrombolysis during 2009-2015.

Disclosures: Dr. Inohara reported receiving research funding from Boston Scientific.

Read the article here.

Citation:

Inohara T et al. Circulation. 2018 Nov 6;138[suppl 1], Abstract A12291.